3[4-[1-(6-Fluorobenzo[b]thiophen-3-yl)-4-piperazinyl]butyl]-2,5,5-trimethyl-4-thiazolidinone: A New Atypical Antipsychotic Agent for the Treatment of Schizophrenia

Journal of Medicinal Chemistry

Volumn 35, Issue 14, 1992, Pages 2712-2715

  Hrib, Nicholas J ^a   Jurcak, John G ^a   Bregna, Deborah E ^a   Dunn, Robert W ^a   Geyer, Harry M ^a   Hartman, Harold B ^a   Roehr, Joachim E ^a   Rogers, Kendra L ^a   Rush, Douglas K ^a   Szewczak, Mark R ^a   Wilmot, Carole A ^a   Conway, Paul G ^a   Szczepanik, Ann Marie ^a  

^a SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT; P 9236; SEROTONIN RECEPTOR; UNCLASSIFIED DRUG;

DRUG ACTIVITY; DRUG RECEPTOR BINDING; DRUG SCREENING; DRUG SELECTIVITY; DRUG SYNTHESIS; EXTRAPYRAMIDAL SYMPTOM; LETTER; PRIORITY JOURNAL; RECEPTOR AFFINITY; SCHIZOPHRENIA;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANIMAL; ANTIPSYCHOTIC AGENTS; MICE; RATS; RECEPTORS, DOPAMINE; RECEPTORS, SEROTONIN; SCHIZOPHRENIA; SUBSTRATE SPECIFICITY; TETRAHYDRONAPHTHALENES; THIAZOLES;

EID: 0026720081     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm00092a024     Document Type: Article

References (17)

1. Fitton, A.; Heel, R. C. Clozapine A Review of its Pharmacological Properties, and Therapeutic Use in Schizophrenia. Drugs 1990, 40, 722.
2. Haga, T.; Toki, T.; Koyanagi, T.; Okada, H.; Yoshida, K.; Imai, O. U.S. Patent 4 783 451, 1988.
3. Beck, J. R. A Direct Synthesis of Benzo[ b ] thiophene-2-carboxylate Esters Involving Nitro Displacement. J. Org. Chem. 1972, 37, 3224-3226.
4. Perregaard, J. K. U.S. Patent No. 4,710,500, Dec. 1,1987.
5. Meltzer, H. Y.; Matsubara, S.; Lee, J-C. Classification of Typical and Antipsychotic Drugs on the basis of Dopamine D-l, D-2, and serotonin2 pK¡ values. J. Pharmacol. Exp. Ther. 1989, 251, 238-246.
6. Altar, C. A.; Wasley, A. M.; Neale, R. F.; Stone, G. A. Typical and Atypical Antipsychotic Occupancy of D2 and S2 Receptors: An Autoradiographic Analysis in Rat Brain. Brain Res. Bull. 1986, 16, 517.
7. Rogers, K. L.; Hartman, H. B.; Roehr, J. E.; Szczepanik, A. M.; Wilmot, C. A.; Broughman, L. R.; Bregna, D. E.; Szewczak, M. R.; Hrib, N. J.; Jurcak, J. G.; Conway, P. G. Neurochemical and Electrophysiological Properties of the Potential Atypical Antipsychotic Drug P-9236. Poster presented at Third IBRO World Congress of Neuroscience, Montréal, Canada, August 1991; Abstract P31.43.
8. Wilmot, C. A.; Szczepanik, A. M. Effects of Acute and Chronic Treatments with Clozapine and Haloperidol on Serotonin (5HT2) and Dopamine (D2) Receptors in the Rat Brain. Brain Res. 1989, 487, 288-298.
9. Ahlenius, S. Antipsychotic-like Properties of the 5HT1A Agonist 8-OH-DPAT in the Rat Pharmacol. Toxicol. 1989, 64, 3-5.
10. Hicks, P. B. The Effect of Serotonergic Agents on Haloperidol-induced Catalepsy. Life Sciences 1990, 47, 1609-1615.
11. Lowe, J. A., III; Seeger, T. F.; Nagel, A. A.; Howard, H. R.; Seymour, P. A.; Heym, J. H.; Ewing, F. E.; Newman M. E.; Schmidt Anne W.; Furman, J. S.; Vincent L. A.; Maloney, P. R.; Robinson, G. L.; Reynolds, L. S.; Vinick, F. J. 1-Naphthylpiperazine Derivatives as Potential Atypical Antipsychotic Agents. J. Med. Chem. 1991, 34,1860-1866.
12. Cook, L.; Weidley, E. Behavioral Effects of Some Psychopharmacological Agents. Ann. N.Y. Acad. Sci. 1957, 66, 740.
13. Protais, P.; Constentin, J.; Schwartz, J. Climbing Behavior Induced by Apomorphine in Mice: A Simple Test for the Study of Dopamine Receptors in Striatum. Psychopharmacol. 1976, 50, 1-6.
14. Janssen, P. A. J.; Niemegeers, C. J. C.; Jageneau, A. H. M. Apomorphine-antagonism in Rats. Arzneim-Forsch. 1960,10, 1003-1005.
15. Lowe, J. A., III; Seeger, T. F.; Vinick, F. J. Atypical Antipsychotics-Recent Findings and New Perspectives. Med. Res. Rev. 1988, 8, 475-497.
16. Moore, N. C.; Gershon, S. Which Atypical Antipsychotics are Identified by Screening Tests? Clinical Neuropharmacol. 1989,12, 167-184.
17. Chiodo, L. A.; Bunney, B. S. Typical and Atypical Neuroleptics: Differential Effects of Chronic Administration on the Activity of A9 and A10 Midbrain Dopaminergic Neurons. J. Neurosci. 1983, 3, 1607-1619.